Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act.
2025 · 4th Quarter (Oct 1 - Dec 31)
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Filed by HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- Not reported
- Expenses
- $30,000.00
- Registrant
- HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
- Filing UUID
- 6fdcc5a8-1a1e-4b7e-89ad-024f151281dc
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
S.257, the Promoting Resilient Supply Chains Act of 2025.
Literal federal measure citations: S.257
Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.